Publication: Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand
dc.contributor.author | B. S. Parekh | en_US |
dc.contributor.author | D. J. Hu | en_US |
dc.contributor.author | S. Vanichseni | en_US |
dc.contributor.author | G. A. Satten | en_US |
dc.contributor.author | D. Candal | en_US |
dc.contributor.author | N. L. Young | en_US |
dc.contributor.author | D. Kitayaporn | en_US |
dc.contributor.author | L. O. Srisuwanvilai | en_US |
dc.contributor.author | S. Rakhtam | en_US |
dc.contributor.author | R. Janssen | en_US |
dc.contributor.author | K. Choopanya | en_US |
dc.contributor.author | T. D. Mastro | en_US |
dc.contributor.other | National Center for Infectious Diseases | en_US |
dc.contributor.other | Bangkok Metropolitan Administration | en_US |
dc.contributor.other | HIV/AIDS Collaboration | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-09-07T09:41:48Z | |
dc.date.available | 2018-09-07T09:41:48Z | |
dc.date.issued | 2001-04-02 | en_US |
dc.description.abstract | The development of a serologic algorithm to determine recent HIV seroconversion, using sensitive/less-sensitive testing strategies, has generated widespread interest in applying this approach to estimate HIV-1 incidence in various populations around the world. To evaluate this approach in non-B subtypes, longitudinal specimens (n = 522) collected from 90 incident infections among injecting drug users in Bangkok (subtype B infection, n = 18; subtype E infection, n = 72) were tested by the 3A11-LS assay. Standardized optical density (SOD) was calculated, using median values, and the window period between seroconversion as determined by sensitive and less sensitive tests was estimated by a maximum-likelihood model described previously. Our results show that the mean window period of the 3A11-LS assay was 155 days (95% CI, 128-189 days) for subtype B but was 270 days (95% CI, 187-349 days) for subtype E specimens from Thailand. About 4% of individuals with incident subtype E infections remained below the threshold (SOD of 0.75), even 2 years after seroconversion. Among the patients with clinical AIDS and declining antibodies, none of the 7 individuals with subtype B, but 10 (8.7%) of 115 with subtype E infections, were misclassified as recent infections. Lowering the cutoff to an SOD of 0.45 for subtype E specimens resulted in a mean window period of 185 days (95% CI, 154-211 days), with all individuals seroconverting, and reduced the number of subtype E-infected patients with AIDS who were misclassified as having recent infection to 2.6%. Our results demonstrate that the 3A11-LS assay has different performance characteristics in detecting recent infections among individuals infected with subtypes B or E. Determining appropriate cutoffs and mean window periods for other HIV-1 subtypes will be necessary before this approach can be reliably implemented in settings where non-B subtypes are common. | en_US |
dc.identifier.citation | AIDS Research and Human Retroviruses. Vol.17, No.5 (2001), 453-458 | en_US |
dc.identifier.doi | 10.1089/088922201750102562 | en_US |
dc.identifier.issn | 08892229 | en_US |
dc.identifier.other | 2-s2.0-0035794280 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/26569 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035794280&origin=inward | en_US |
dc.subject | Immunology and Microbiology | en_US |
dc.subject | Medicine | en_US |
dc.title | Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035794280&origin=inward | en_US |